Dr Reddy’s Labs Gains After U.S. Unit Files NDA For Migraine Drug — Shares of the Hyderabad-based drug maker rose as much as 2.6 percent to Rs 2,135 after its U.S. subsidiary Promius Pharma filed for New Drug Application (NDA) for its migraine candidate.
